Literature DB >> 12925042

Resveratrol modulates apoptosis and oxidation in human blood mononuclear cells.

G A Losa1.   

Abstract

BACKGROUND: We examined the effect of resveratrol (RS), a nonflavonoid polyphenolic phytoalexin found in grapes and red wine, and RS coincubated with the oxidant 2-deoxy-D-ribose (dR), on apoptosis and on the oxidative metabolic status of normal human peripheral blood mononuclear cells (PBMNCs) isolated ex vivo from healthy donors.
MATERIAL AND METHODS: Apoptosis was measured by changes of membrane permeability to propidium iodide (PI), plasma membrane exposure of phosphatidylserine (PS) and intracellular caspase activity. Oxidative status was assessed by recording the intracellular glutathione concentration (GSH), the activities of the enzymes y-glutamyltransferase (y-GT) and glutathione-S-transferase (GST), and intracellular lipid peroxidation (MDA).
RESULTS: Neither apoptotic nor oxidative parameters were affected by culturing PBMNCs in medium containing RS up to 20 micro M for 5 days, while the frequency of cells with intermediate permeability to PI (17% +/- 5) increased at 50 micro M of RS. Thus resveratrol was slightly toxic, but there was little apoptosis in these cells. Peripheral blood mononuclear cells were also grown first in medium plus RS for 24 h and then for 96 h in medium containing RS plus 10 mM of dR, an oxidant sugar that is apoptogenic for human lymphocytes. The apoptotic changes triggered by dR were counteracted by the phytoalexin in a dose-dependent manner, but RS activity was absent at the lowest concentration (5 micro M) and significantly reduced at the highest concentration used (50 micro M). In PBMNCs coincubated with 20 micro M of RS and 10 mM of dR the antioxidant effect of RS manifested with a significant reduction of caspases-3, -8, y-GT, GST activities and MDA content.
CONCLUSIONS: Peripheral blood mononuclear cells acquire antioxidant capacity when treated with RS. Grape resveratrol may make a useful dietary supplement for minimizing oxidative injury in immune-perturbed states and human chronic degenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12925042     DOI: 10.1046/j.1365-2362.2003.01219.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  16 in total

1.  Protective activity of a novel resveratrol analogue, HS-1793, against DNA damage in 137Cs-irradiated CHO-K1 cells.

Authors:  Min Ho Jeong; Kwang Mo Yang; Dong Hyeok Jeong; Chang Geun Lee; Su Jung Oh; Soo Kyung Jeong; Ki Won Lee; Young Rae Jo; Wol Soon Jo
Journal:  J Radiat Res       Date:  2014-01-07       Impact factor: 2.724

Review 2.  Phenylpropanoids in radioregulation: double edged sword.

Authors:  Wanyeon Kim; Ki Moon Seong; BuHyun Youn
Journal:  Exp Mol Med       Date:  2011-06-30       Impact factor: 8.718

3.  Combination of resveratrol-containing collagen with adipose stem cells for craniofacial tissue-engineering applications.

Authors:  Chih-Chien Wang; Chih-Hsin Wang; Hsiang-Cheng Chen; Juin-Hong Cherng; Shu-Jen Chang; Yi-Wen Wang; Adrienne Chang; Jue-Zong Yeh; Yi-Huei Huang; Cheng-Che Liu
Journal:  Int Wound J       Date:  2018-03-13       Impact factor: 3.315

Review 4.  Multifaceted approach to resveratrol bioactivity: Focus on antioxidant action, cell signaling and safety.

Authors:  Peter Kovacic; Ratnasamy Somanathan
Journal:  Oxid Med Cell Longev       Date:  2010 Mar-Apr       Impact factor: 6.543

5.  Resveratrol reduces radiation-induced chromosome aberration frequencies in mouse bone marrow cells.

Authors:  Ronald E Carsten; Annette M Bachand; Susan M Bailey; Robert L Ullrich
Journal:  Radiat Res       Date:  2008-06       Impact factor: 2.841

6.  trans-Resveratrol, an extract of red wine, inhibits human eosinophil activation and degranulation.

Authors:  Y Tan; L H K Lim
Journal:  Br J Pharmacol       Date:  2008-09-08       Impact factor: 8.739

7.  Resveratrol: French paradox revisited.

Authors:  Betul Catalgol; Saime Batirel; Yavuz Taga; Nesrin Kartal Ozer
Journal:  Front Pharmacol       Date:  2012-07-17       Impact factor: 5.810

Review 8.  Metabolic engineering of yeast and plants for the production of the biologically active hydroxystilbene, resveratrol.

Authors:  Philippe Jeandet; Bertrand Delaunois; Aziz Aziz; David Donnez; Yann Vasserot; Sylvain Cordelier; Eric Courot
Journal:  J Biomed Biotechnol       Date:  2012-05-13

Review 9.  Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans.

Authors:  J Gambini; M Inglés; G Olaso; R Lopez-Grueso; V Bonet-Costa; L Gimeno-Mallench; C Mas-Bargues; K M Abdelaziz; M C Gomez-Cabrera; J Vina; C Borras
Journal:  Oxid Med Cell Longev       Date:  2015-06-28       Impact factor: 6.543

10.  Botanical compounds: effects on major eye diseases.

Authors:  Tuan-Phat Huynh; Shivani N Mann; Nawajes A Mandal
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-17       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.